Title : Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation.

Pub. Date : 2016 Feb 9

PMID : 26857243






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In the cohort of WDTC with distant metastasis, patients with wild-type BRAF and TERT promoter had a significantly higher response rate after radioiodine therapy (p = 0.024), whereas the BRAF V600E mutation was significantly correlated with progressive disease (p = 0.025). Iodine-131 telomerase reverse transcriptase Homo sapiens